Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and daunorubicin

quinazolines has been researched along with daunorubicin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Assaraf, YG; Molina, A; Schimke, RT; Sherwood, SW1
Charlton, P; Dale, I; Dangerfield, W; Depledge, P; Dodd, R; Faint, R; Hancox, TC; Hassan, S; Milton, J; Pretswell, I; Ryder, H; Wang, S1
Bandobashi, K; Ikezoe, T; Koeffler, HP; Komatsu, N; Kuwayama, Y; Nishioka, C; Taguchi, H; Taniguchi, A; Tasaka, T; Togitani, K; Yang, J; Yokoyama, A1
Heinrich, MC; Kampa, KM; Schittenhelm, MM; Yee, KW1
de la Haye, A; Gütschow, M; Häcker, HG; Schnakenburg, G; Sterz, K; Wiese, M1
Chalfant, CE; Goehe, RW; Hawkins, AJ; Massiello, A; Mayton, EK; Mukerjee, P; Murudkar, CS; Park, MA; Pinkerman, RL; Shultz, JC; Wijesinghe, DS1
Grundy, M; Pallis, M; Russell, NH; Seedhouse, C1
Abuo-Rahma, GEA; Badr, M; Bass, AKA; El-Zoghbi, MS; Mohamed, MFA; Nageeb, EM1

Reviews

1 review(s) available for quinazolines and daunorubicin

ArticleYear
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
    European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

    Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors

2021

Other Studies

7 other study(ies) available for quinazolines and daunorubicin

ArticleYear
Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin.
    Cancer research, 1990, Aug-15, Volume: 50, Issue:16

    Topics: Animals; Cell Line; Colchicine; Cricetinae; Cricetulus; Daunorubicin; Drug Resistance; Female; Flow Cytometry; Folic Acid Antagonists; Kinetics; Methotrexate; Ovary; Quinazolines; Tetrahydrofolate Dehydrogenase; Trimetrexate; Verapamil

1990
Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance.
    Bioorganic & medicinal chemistry letters, 2002, Feb-25, Volume: 12, Issue:4

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured

2002
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.
    Blood, 2007, Sep-15, Volume: 110, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Case-Control Studies; Cell Cycle; Cell Proliferation; Colony-Forming Units Assay; Daunorubicin; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Immunoblotting; Leukemia; Mice; Mice, Inbred BALB C; Organophosphates; Protein Serine-Threonine Kinases; Quinazolines; Thymidine; Transplantation, Heterologous; Tubulin Modulators; Vincristine

2007
The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin.
    Cell cycle (Georgetown, Tex.), 2009, Aug-15, Volume: 8, Issue:16

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Apoptosis; Cell Line; Cell Proliferation; Cytarabine; Daunorubicin; Drug Synergism; Flow Cytometry; fms-Like Tyrosine Kinase 3; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Piperazines; Quinazolines

2009
Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity.
    Bioorganic & medicinal chemistry letters, 2009, Nov-01, Volume: 19, Issue:21

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Crystallography, X-Ray; Daunorubicin; Drug Resistance, Neoplasm; Humans; Molecular Conformation; Pyrimidines; Quinazolines; Substrate Specificity

2009
SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
    Molecular cancer research : MCR, 2011, Volume: 9, Issue:7

    Topics: Alternative Splicing; Carcinoma, Non-Small-Cell Lung; Caspase 9; Cell Line, Tumor; Cisplatin; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enhancer Elements, Genetic; Erlotinib Hydrochloride; HeLa Cells; Humans; Introns; Lung Diseases; Nuclear Proteins; Paclitaxel; Quinazolines; RNA Precursors; RNA Splice Sites; RNA-Binding Proteins; RNA, Antisense; RNA, Small Interfering; Serine-Arginine Splicing Factors

2011
P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.
    BMC cancer, 2011, Jun-16, Volume: 11

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Aurora Kinase B; Aurora Kinases; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Female; Histones; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Male; Neoplasm Proteins; Organophosphates; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Quinazolines

2011